Owners of this ASX 200 share are soon going to receive a bigger dividend

Investors in this healthcare company are about to get a healthy cash boost.

| More on:
A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads some news.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Sonic Healthcare shares have gone ex-dividend
  • Investors will receive a 42 cents per share dividend in two weeks
  • The company remains much more profitable since the start of the COVID pandemic

The Sonic Healthcare Ltd (ASX: SHL) share price is in the red — and has been for most of today's trading — after the S&P/ASX 200 Index (ASX: XJO) healthcare share went ex-dividend.

Last month was reporting season, when investors learned how their companies had performed in the period to December 2022.

Some businesses also declared their latest dividends.

Sonic Healthcare was one of the businesses that announced its dividend, with another increase for investors.

Sonic Healthcare shares goes ex-dividend

The board of the ASX 200 share decided to declare an interim dividend of 42 cents per share. That represents an increase of 5% compared to the prior corresponding period.

Sonic Healthcare shares went ex-dividend today, meaning that investors who buy shares today aren't entitled to that 42 cents dividend per share. This will be paid on 22 March 2023.

Investors who were too late to buy shares will need to wait another six months for the next half-year dividend. However, the business has a "progressive dividend policy", so the next dividend may also be higher than what was paid in the prior corresponding period of the previous financial year.

How was the ASX 200 share's dividend funded?

The ASX 200 share reported that in the first six months of the 2023 financial year, its total revenue was $4.08 billion and earnings per share (EPS) was 80.9 cents. Those numbers were up 22% and 52% respectively, compared to the pre-COVID result of the FY20 first half.

Those numbers included its base business revenue of $3.7 billion, which was up 9% year over year. The base business margins were "in line" with pre-pandemic levels. It's also benefiting from catch-up testing which is now going up after the pandemic and its extensive COVID testing regimes.

The business is pursuing new contracts and potential acquisitions which could help it grow further from here.

Sonic Healthcare share price snapshot

Since the beginning of 2023, the ASX 200 healthcare share has risen around 10%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Healthcare Shares

Are CSL and this ASX 200 healthcare stock buys in January?

Is now a good time to pick up these shares? Let's see what analysts are saying.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Communication Shares

2 ASX shares expected to report strong earnings this quarter

Analysts expect a strong set of upcoming numbers for these ASX heavyweights

Read more »

A women has her eyes checked at the optometrist.
Healthcare Shares

Is Medibank stock a good buy?

Can this company provide healthy returns?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »